← FDA Drug Approvals (Drugs@FDA)

BIAXIN

NDA · New Drug Application · Sponsor: ABBVIE · Approved 1993-12-23

Drug application

FDA Application #

NDA050698

Application type

New Drug Application

Brand name

BIAXIN

Generic name

Clarithromycin

Active ingredients

CLARITHROMYCIN

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

1993-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown